How do I hire a fractional revenue leader for a medtech company in 2027?
Direct Answer
You hire a fractional revenue leader for medtech by first determining whether your company is pre-revenue, early-stage (under $5M ARR), or scaling ($5M+ ARR), because the required expertise and time commitment differ sharply. Then you search for candidates who have sold into hospitals, clinics, or medical device distributors—not just B2B software—and who understand HIPAA, FDA clearance timelines, and long procurement cycles. Expect to pay $6k–$18k/month for 2–10 days of work per week, with the lower end for advisory-only roles and the upper end for hands-on pipeline management. The best candidates often come from referrals in Pavilion or RevOps Co-op, not job boards.
Why Medtech Is Different from General SaaS
Medtech revenue leadership is not a plug-and-play role. The buying committee includes clinicians, procurement officers, legal, compliance, and sometimes a hospital board—each with distinct concerns. A fractional CRO who built a $20M SaaS business may fail here because they lack experience with FDA 510(k) clearance timelines, HIPAA-compliant data handling, or the need for clinical evidence in sales collateral. In 2027, medtech companies also face tighter reimbursement scrutiny from insurers and Medicare, so your fractional leader must understand value-based pricing and health economics—not just subscription metrics.
The procurement process in hospitals and large clinics is notoriously slow. A single deal can require 10+ meetings, vendor credentialing, and security reviews that take months. A fractional leader who has never navigated this will burn your runway. You need someone who can map the stakeholder market and accelerate approvals without cutting corners on compliance.
How to Match Scope to Stage
Your company's stage dictates the fractional leader's focus. For pre-revenue medtech, you need a go-to-market architect who can define your ICP, pricing, and channel strategy—often 2–3 days per week. Expect to pay $6k–$10k/month and offer 1%–2% equity. The leader should have launched a regulated product before and can help you avoid common pitfalls like pricing too low or targeting the wrong specialty.
For $1M–$5M ARR, you need a player-coach who can personally close deals while building a repeatable sales process. This requires 4–5 days per week and costs $12k–$18k/month. Look for someone who has hired and managed medtech sales reps and can implement a CRM (Salesforce or HubSpot) with proper pipeline stages for long cycles. They should also be comfortable with Gong or Clari for deal inspection.
For $5M+ ARR, a fractional leader can focus on team scaling, channel partnerships, and board reporting. You might need only 2–3 days per week for strategy, with a full-time VP of Sales handling execution. Cost drops to $8k–$14k/month, but expect to pay a performance bonus (5%–10% of new ARR). The leader should have scaled a medtech company past $20M and be able to recruit and retain top talent.
Where to Find Candidates
Referrals are the strongest signal. Ask your network in healthtech accelerators, medtech conferences (e.g., AdvaMed, HIMSS), or investors who back regulated companies. A warm introduction to a fractional leader with 3+ medtech engagements is worth more than a cold outreach to 20 candidates.
How to Vet and Onboard
Your vetting process must include a deep-dive on deal history. Ask: "Walk me through the last three deals you closed in medtech. What was the buying committee? How long did each take? What caused delays?" Listen for specifics about regulatory hurdles, pricing negotiations with group purchasing organizations (GPOs), and clinical champions. If they cannot name the stakeholders or the timeline, move on.
Check references with former medtech clients. Ask: "Did this person understand the sales cycle length? Did they help you navigate compliance? Would you hire them again?" If a reference hesitates or says "they were great but didn't know the industry," that is a red flag.
Onboarding should include a 30-day immersion where the fractional leader meets your clinical advisors, reviews your sales collateral for compliance, and audits your CRM data. They should deliver a 60-day plan with specific milestones: pipeline generation targets, process improvements, and hiring recommendations. Use Salesforce or HubSpot to track progress, and hold weekly check-ins.
Measuring Success and When to Transition
Success for a fractional medtech revenue leader is not just revenue. It is pipeline velocity, deal progression through stages, and team capability building. In 2027, use Clari or Gong to track conversion rates at each stage and time to close. Set quarterly OKRs tied to these metrics, not vanity metrics like calls made.
Plan for a transition to full-time when your ARR exceeds $10M or when the fractional leader is spending more than 4 days per week consistently. At that point, you should have a full-time VP of Sales or CRO who can take over execution. The fractional leader can stay on as a board advisor or coach for 1–2 days per month.
FAQ
What is the typical cost range for a fractional medtech revenue leader in 2027? $6,000 to $18,000 per month, depending on days per week (2–10), company stage, and whether equity is included. Pre-revenue companies pay the lower end; $1M–$5M ARR companies pay the upper end. Equity typically ranges from 0.5% to 2%.
How many days per week should I expect a fractional CRO to work? 2–5 days per week. Pre-revenue or advisory roles need 2–3 days; hands-on pipeline management for $1M–$5M ARR needs 4–5 days. Anything less than 2 days is likely insufficient for medtech's long sales cycles.
Can a fractional leader work remotely for a medtech company based in a specific city? Yes. Most fractional medtech CROs work remote or hybrid, especially if your company is in a city with thin local supply (e.g., not Boston, San Diego, or Minneapolis). They will travel for key customer meetings and board sessions.
How do I know if a fractional leader has enough medtech experience? Ask for specific examples of deals involving FDA clearance, HIPAA compliance, hospital procurement, or GPO negotiations. If they cannot name the regulatory body or the buying committee roles, they lack the depth needed.
What happens if the fractional leader is not a good fit? Include a 30-day trial period in your contract. If it does not work, part ways with 2–4 weeks' notice. This is the main advantage of fractional over full-time—low risk of a costly hiring mistake.
Should I offer equity to a fractional revenue leader? Yes, for early-stage companies (pre-revenue to $5M ARR). Equity aligns incentives and reduces cash cost. Typical range is 0.5%–2% with a 2–4 year vesting schedule. For $5M+ ARR, cash-only or cash-plus-bonus is more common.
How do I evaluate a fractional leader's past results without case studies? Ask for reference calls with former medtech clients. Listen for specifics: "They helped us reduce sales cycle from 14 months to 10 months" or "They built a pipeline that generated $2M in new ARR within 6 months." Avoid vague claims like "they drove growth."